Halofantrine
66051-74-9CCCCN(CCCC)CCC(O)c1cc2c(Cl)cc(Cl)cc2c2cc(C(F)(F)F)ccc12FOHHNHSLJDZUGQ-UHFFFAOYSA-N3-(dibutylamino)-1-[1,3-dichloro-6-(trifluoromethyl)-9-phenanthrenyl]-1-propanol is a member of phenanthrenes.
66051-74-9、66051-76-1、69756-53-2DTXSID0023119CHEMBL1107CHEBI:94392安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。
Drug-Induced Liver Injury Severity and Toxicity (DILIst)
Halofantrine
DILI Positive
DOI:10.1016/j.drudis.2019.09.022
Q2OS4303HZ
HALOFANTRINE
Established Pharmacologic Class [EPC] - Antimalarial
Halofantrine is an Antimalarial.
説明Halofantrine is an orally-active blood schizonticide reportedly highly effective in the treatment of fulcipurum malaria and other types of parasitemia. Cure rate is claimed to be over 95%.
一般的な説明Structurally, halofantrine differs from allother antimalarial drugs. It is a good example of drug designthat incorporates bioisosteric principles as evidenced by thetrifluromethyl moiety. Halofantrine is a schizonticide and has no affect on the sporozoite, gametocyte,or hepatic stages. Both the parent compound and Ndesbutylmetabolite are equally active in vitro. Halfantrine’sspecific mechanism of action against the parasite is notknown. There is contradictory evidence that its mechanismranges from requiring heme to disrupting the mitochondria.There is a prominent warning that halfantrine can affectnerve conduction in cardiac tissue.
読み込み中…